Investors

  • CAPITAL STRUCTURE AND QUOTE
  • FINANCIAL STATEMENTS
  • AGM

Capital Structure

Shares Outstanding

39,685,639

Warrants

22,499,998

7,499,998 @ $0.15

March 15, 2026

1,000,000 @ $0.50

August 29, 2027

4,000,000 @ $0.06

February 24, 2028

10,000,000 @ $0.12

November 14, 2028

Options

400,400

100,000 @ $1.30

January 1, 2026

200,000 @ $0.55

November 18, 2026

54,000 @ $3.00

March 7, 2027

15,000 @ $3.60

May 29, 2027

25,000 @ $5.50

May 29, 2027

6,400 @ $3.90

April 20, 2028

Fully Diluted

62,586,037
As of November 17, 2025

Capital Structure

Stock Exchange

TSX Venture

Transfer Agent

Computershare

Auditors

Grant Thornton LLP

Lawyers

Farris Law LLP

FINANCIAL STATEMENTS

Select Year:

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
Financial Statements
Q1 2026 - Financial Statements Q1 2026 - MD&A
Financial Statements
Q4 2025 - Financial Statements Q4 2025 - MD&A
Q3 2025 - Financial Statements Q3 2025 - MD&A
Q2 2025 - Financial Statements Q2 2025 - MD&A
Q1 2025 - Financial Statements Q1 2025 - MD&A
Financial Statements
Q4 2024 - Financial Statements Q4 2024 - MD&A
Q3 2024 - Financial Statements Q3 2024 - MD&A
Q2 2024 - Financial Statements Q2 2024 - MD&A
Q1 2024 - Financial Statements Q1 2024 - MD&A
Financial Statements
Q4 2023 - Financial Statements Q4 2023 - MD&A
Q3 2023 - Financial Statements Q3 2023 - MD&A
Q2 2023 - Financial Statements Q2 2023 - MD&A
Q1 2023 - Financial Statements Q1 2023 - MD&A
Financial Statements
Q4 2022 - Financial Statements Q4 2022 - MD&A
Q3 2022 - Financial Statements Q3 2022 - MD&A
Q2 2022 - Financial Statements Q2 2022 - MD&A
Q1 2022 - Financial Statements Q1 2022 - MD&A
Financial Statements
Q4 2021 - Financial Statements Q4 2021 - MD&A
Q3 2021 - Financial Statements Q3 2021 - MD&A
Q2 2021 - Financial Statements Q2 2021 - MD&A
Q1 2021 - Financial Statements Q1 2021 - MD&A
Financial Statements
Q4 2020 - Financial Statements Q4 2020 - MD&A
Q3 2020 - Financial Statements Q3 2020 - MD&A
Q2 2020 - Financial Statements Q2 2020 - MD&A
Q1 2020 - Financial Statements Q1 2020 - MD&A
Financial Statements
Q4 2019 - Financial Statements Q4 2019 - MD&A
Q3 2019 - Financial Statements Q3 2019 - MD&A
Q2 2019 - Financial Statements Q2 2019 - MD&A
Q1 2019 - Financial Statements Q1 2019 - MD&A
Financial Statements
Q4 2018 - Financial Statements Q4 2018 - MD&A
Q3 2018 - Financial Statements Q3 2018 - MD&A
Q2 2018 - Financial Statements Q2 2018 - MD&A
Q1 2018 - Financial Statements Q1 2018 - MD&A
Financial Statements
Q4 2017 - Financial Statements Q4 2017 - MD&A
Q3 2017 - Financial Statements Q3 2017 - MD&A
Q2 2017 - Financial Statements Q2 2017 - MD&A
Q1 2017 - Financial Statements Q1 2017 - MD&A
Financial Statements
Year End 2016 - Financial Statements Year End 2016 - Management Discussion & Analysis
Q3 2016 - Financial Statements Q3 2016 - MD&A

AGM

Notice of Meeting Combined Notice of Meeting and Information Circular Form of Proxy Financial Statements Request Form
  • CAPITAL STRUCTURE AND QUOTE
  • FINANCIAL STATEMENTS
  • AGM

Get in touch

info@mexicangold.ca

Phone: (604) 612-2111

Contact us and Request Information